Ibrutinib does not affect ristocetin-induced platelet aggregation evaluated by light transmission aggregometry in chronic lymphocytic leukemia patients

Haematologica. 2018 Mar;103(3):e119-e122. doi: 10.3324/haematol.2017.179044. Epub 2017 Dec 14.
No abstract available

Publication types

  • Letter
  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenine / analogs & derivatives
  • Aged
  • Aged, 80 and over
  • Female
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / blood*
  • Male
  • Middle Aged
  • Piperidines
  • Platelet Aggregation / drug effects*
  • Platelet Function Tests / methods
  • Pyrazoles / pharmacology*
  • Pyrimidines / pharmacology*
  • Ristocetin / pharmacology

Substances

  • Piperidines
  • Pyrazoles
  • Pyrimidines
  • Ristocetin
  • ibrutinib
  • Adenine